{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(8)"],"submitter":["Comans T"],"pubmed_abstract":["<h4>Background and objectives</h4>Recently, cost-benefit analysis has been increasingly used to evaluate the value of interventions for dementia. This study aims to synthesize the methodology used in cost-benefit analysis (CBA) for dementia interventions.<h4>Research design and methods</h4>We conducted a scoping review with comprehensive systematic searches for original peer-reviewed articles published from January 2010 to December 2023, and included the studies if they (1) performed a CBA of interventions for dementia, (2) described either cost or benefit items, and (3) performed quantitative data analysis on either costs or benefits. The review adhered to the PRISMA Extension for Scoping Reviews Checklist to write the report.<h4>Results</h4>Of the 3415 articles found from the search, 15 "],"journal":["Innovation in aging"],"pagination":["igaf084"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12448809"],"repository":["biostudies-literature"],"pubmed_title":["Cost-benefit analysis of interventions for dementia: a scoping review."],"pmcid":["PMC12448809"],"pubmed_authors":["Comans T","Low LF","Barcenilla-Wong A","Simpson D","Vasquez P","Dao-Tran TH","Balasooriya N","Zhou J","Nguyen KH"],"additional_accession":[]},"is_claimable":false,"name":"Cost-benefit analysis of interventions for dementia: a scoping review.","description":"<h4>Background and objectives</h4>Recently, cost-benefit analysis has been increasingly used to evaluate the value of interventions for dementia. This study aims to synthesize the methodology used in cost-benefit analysis (CBA) for dementia interventions.<h4>Research design and methods</h4>We conducted a scoping review with comprehensive systematic searches for original peer-reviewed articles published from January 2010 to December 2023, and included the studies if they (1) performed a CBA of interventions for dementia, (2) described either cost or benefit items, and (3) performed quantitative data analysis on either costs or benefits. The review adhered to the PRISMA Extension for Scoping Reviews Checklist to write the report.<h4>Results</h4>Of the 3415 articles found from the search, 15 ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-06-05T11:39:22.221Z","creation":"2026-05-16T03:12:56.041Z"},"accession":"S-EPMC12448809","cross_references":{"pubmed":["40979466"],"doi":["10.1093/geroni/igaf084"]}}